Brian L. Batley

In Vitro Pharmacological Characterization of PD 166285, a New Nanomolar Potent and Broadly Active Protein Tyrosine Kinase Inhibitor

Robert L. Panek, Gina H. Lu, S. KLUTCHKO et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 94 citations

Medicine, Medicinal Chemistry, Pharmacology +17

In Vitro Biological Characterization and Antiangiogenic Effects of PD 166866, a Selective Inhibitor of the FGF-1 Receptor Tyrosine Kinase

Robert L. Panek, Gina H. Lu, Tawny K. Dahring et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 89 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis and Tyrosine Kinase Inhibitory Activity of a Series of 2-Amino-8<i>H</i>-pyrido[2,3-<i>d</i>]pyrimidines:  Identification of Potent, Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors

Diane H. Boschelli, Zhipei Wu, S. KLUTCHKO et al. · Journal of Medicinal Chemistry · 1998 · 84 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors

Annette M. Doherty, Ila Sircar, Brian E. Kornberg et al. · Journal of Medicinal Chemistry · 1992 · 62 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Soluble 2-Substituted Aminopyrido[2,3-<i>d</i>]pyrimidin-7-yl Ureas. Structure−Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity

Mel C. Schroeder, James M. Hamby, Cleo J. C. Connolly et al. · Journal of Medicinal Chemistry · 2001 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15